Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus

Sobel BE: Optimizing cardiovascular outcomes in diabetes mellitus. Am J Med. 2007, 120: 3-11. 10.1016/j.amjmed.2007.07.002.

Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC: Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med. 2007, 147: 149-55.

Wade AO, Cordingley JJ: Glycaemic control in critically ill patients with cardiovascular disease. Curr Opin Crit Care. 2006, 12: 437-43. 10.1097/01.ccx.0000244123.39247.b9.

Johansen JS, Harris AK, Rychly DJ, Ergul A: Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol. 2005, 4: 5-10.1186/1475-2840-4-5.

Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007, 39: 44-84. 10.1016/j.biocel.2006.07.001.

Zhang DX, Gutterman DD: Mitochondrial reactive oxygen species-mediated signaling in endothelial cells. Am J Physiol Heart Circ Physiol. 2007, 292: 2023-31. 10.1152/ajpheart.01283.2006.

Da Ros R, Assaloni R, Ceriello A: Molecular targets of diabetic vascular complications and potential new drugs. Curr Drug Targets. 2005, 6: 503-9. 10.2174/1389450054021855.

Schleicher E, Friess U: Oxidative stress, AGE, and atherosclerosis. Kidney Int Suppl. 2007, 106: 17-26. 10.1038/sj.ki.5002382.

Tan AL, Forbes JM, Cooper ME: AGE, RAGE, and ROS in diabetic nephropathy. Semin Nephrol. 2007, 27: 130-43. 10.1016/j.semnephrol.2007.01.006.

Hammes HP: Pathophysiological mechanisms of diabetic angiopathy. J Diabetes Complications. 2003, 17: 16-9. 10.1016/S1056-8727(02)00275-1.

Nishikawa T, Araki E: Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal. 2007, 9: 343-53. 10.1089/ars.2006.1458.

Mokini Z, Chiarelli F: The molecular basis of diabetic microangiopathy. Pediatr Endocrinol Rev. 2006, 4: 138-52.

Maritim AC, Sanders RA, Watkins JB: Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003, 7: 24-38. 10.1002/jbt.10058.

Yung LM, Leung FP, Yao X, Chen ZY, Huang Y: Reactive oxygen species in vascular wall. Cardiovasc Hematol Disord Drug Targets. 2006, 6: 1-19.

Fumeron F, Reis AF, Velho G: Genetics of macrovascular complications in diabetes. Curr Diab Rep. 2006, 6: 162-8. 10.1007/s11892-006-0028-5.

Kinnula VL, Lehtonen S, Koistinen P, Kakko S, Savolainen M, Kere J, Ollikainen V, Laitinen T: Two functional variants of the superoxide dismutase genes in Finnish families with asthma. Thorax. 2004, 59: 116-9. 10.1136/thorax.2003.005611.

Hart PJ: Pathogenic superoxide dismutase structure, folding, aggregation and turnover. Curr Opin Chem Biol. 2006, 10: 131-8. 10.1016/j.cbpa.2006.02.034.

Zelko IN, Mariani TJ, Folz RJ: Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med. 2002, 33: 337-49. 10.1016/S0891-5849(02)00905-X.

Leopold JA, Loscalzo J: Oxidative enzymopathies and vascular disease. Arterioscler Thromb Vasc Biol. 2005, 25: 1332-40. 10.1161/01.ATV.0000163846.51473.09.

McCord JM, Fridowich I: Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969, 243: 6049-6055.

Nahon P, Sutton A, Pessayre D: Genetic dimorphism in superoxide dismutase and susceptibility to alcoholic cirrhosis, hepatocellular carcinoma and death. Clin Gastroenterol Hepatol. 2005, 3: 292-8. 10.1016/S1542-3565(04)00718-9.

Nomiyama T, Tanaka Y, Piao L, Nagasaka K, Sakai K, Ogihara T, Nakajima K, Watada H, Kawamori R: The polymorphism of manganese superoxide dismutase is associated with diabetic nephropathy in Japanese type 2 diabetic patients. J Hum Genet. 2003, 48: 138-41.

Ukkola O, Erkkilä PH, Savolainen MJ, Kesäniemi YA: Lack of association between polymorphisms of catalase, copper-zinc superoxide dismutase (SOD), extracellular SOD and endothelial nitric oxide synthase genes and macroangiopathy in patients with type 2 diabetes mellitus. J Intern Med. 2001, 249: 451-9. 10.1046/j.1365-2796.2001.00828.x.

Chistyakov DA, Savost'anov KV, Zotova EV, Nosikov VV: Polymorphisms in the Mn-SOD and EC-SOD genes and their relationship to diabetic neuropathy in type 1 diabetes mellitus. BMC Med Genet. 2001, 2: 4-10.1186/1471-2350-2-4.

Song F, Jia W, Yao Y, Hu Y, Lei L, Lin J, Sun X, Liu L: Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes. Clin Sci (Lond). 2007, 112: 599-606.

Nemoto M, Nishimura R, Sasaki T, Hiki Y, Miyashita Y, Nishioka M, Fujimoto K, Sakuma T, Ohashi T, Fukuda K, Eto Y, Tajima N: Genetic association of glutathione peroxidase-1 with coronary artery calcification in type 2 diabetes: a case control study with multi-slice computed tomography. Cardiovasc Diabetol. 2007, 7: 23-10.1186/1475-2840-6-23.

Lee SJ, Choi MG, Kim DS, Kim TW: Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients. Metabolism. 2006, 55: 1-7. 10.1016/j.metabol.2005.04.030.

Lee SJ, Choi MG: Association of manganese superoxide dismutase gene polymorphism (V16A) with diabetic macular edema in Korean type 2 diabetic patients. Metabolism. 2006, 55: 1681-8. 10.1016/j.metabol.2006.08.011.

Shimoda-Matsubayashi S, Atsum Mine Hob, Kayashi Takagaw, Na-Hattori Y, Shimizu Y, Mizino Y: Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. Biochem Biophys Res Commun. 1996, 226: 561-565. 10.1006/bbrc.1996.1394.

Shimoda-Matsubayashi S, Hattori Y, Matsumine H, Shinohara A, Yoritaka A, Mori H, Kondo T, Chiba M, Mizuno Y: MnSOD activity and protein in a patient with chromosome 6-linked autosomal recessive parkinsonism in comparison with Parkinson's disease and control. Neurology. 1997, 49: 1257-1262.

Rolo AP, Palmeira CM: and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol. 2006, 212: 167-78. 10.1016/j.taap.2006.01.003.

Faraci FM, Didion SP: Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol. 2004, 24: 1367-73. 10.1161/01.ATV.0000133604.20182.cf.

Forsberg L, Lyrens L, de Faire U, Morgenstern R: A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med. 2001, 30: 500-5. 10.1016/S0891-5849(00)00487-1.

Jiang Z, Akey JM, Shi J, Xiong M, Wang Y, Shen Y, Xu X, Chen H, Wu H, Xiao J, Lu D, Huang W, Jin L: A polymorphism in the promoter region of catalase is associated with blood pressure levels. Hum Genet. 2001, 109: 95-98. 10.1007/s004390100553.

Chistiakov DA, Savost'anov KV, Turakulov RI, Titovich EV, Zilberman LI, Kuraeva TL, Dedov II, Nosikov VV: A new type 1 diabetes susceptibility locus containing the catalase gene (chromosome 11p13) in a Russian population. Diabetes Metab Res Rev. 2004, 20: 219-24. 10.1002/dmrr.442.

Pask R, Cooper JD, Walker NM, Nutland S, Hutchings J, Dunger DB, Nejentsev S, Todd JA: No evidence for a major effect of two common polymorphisms of the catalase gene in type 1 diabetes susceptibility. Diabetes Metab Res Rev. 2006, 22: 356-60. 10.1002/dmrr.628.